diabetics

DexCom Inc.'s STS-7 System: Seven-day Glucose Monitor, Approved by the FDA

Filed in archive Diabetics' Device on June 5, 2007

DexCom Inc.'s STS-7 System: Seven-day Glucose Monitor, Approved by the FDA
A device that measures glucose levels continuously for up to seven days in diabetics has recently been approved by the FDA.

While a standard fingerstick test records a person's glucose level as a snapshot in time, the STS-7 Continuous Glucose Monitoring System measures glucose levels every five minutes throughout a seven-day period.

The FDA said that additional information can be used to track patterns in glucose levels throughout the week that wouldn't be captured by fingerstick measurements.


The said device - STS-7 Continuous Glucose Monitoring System - is a product of a San Diego company DexCom Inc. that utilizes a disposable sensor placed just below the skin in the abdomen to measure the level of glucose in the fluid found in the body's tissues - then an alarm sounds off when a patient's glucose level reaches the pre-set lows or pre-set highs.

Read the full report.



Permalink: DexCom Inc.'s STS-7 System: Seven-day Glucose Monitor, Approved by the FDA

Tags: glucose  level  monitor  STS7  Continuous  Glucose  Monitoring  System 

Vote for DexCom Inc.'s STS-7 System: Seven-day Glucose Monitor, Approved by the FDA:

  • Currently 7.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.50 out of 6 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
TwitterFollow us on Twitter!
Tagcloud
Most Popular   Best of   Blogs, Blogging & Blogosphere   Challenges   Developments   Diabetics' Device   Did you know   Diet   Education   Exercise   Family Matters   Friends   Fun   Information   Information about   Inspiration   Interviews   Lifestyle   Misc   News   Notable